NT5E and melanoma: Further, upregulation of CD73 was shown in an invasive and inflammatory mouse melanoma model and is implicated in regulating phenotype switching from proliferative to an invasive mesenchymal-like state in melanoma patients who progress while on immunotherapy [33].